Tuesday, September 29, 2020 5:14:03 PM
Good observation. From a previous pr this was also disclosed a year ago as follows..."This trial was conducted on 236 WIRB (Western Institutional Review Board) approved and consented patients. Surgeries consisted of Level 1 and Level 2 bleeds on the Lewis bleeding scale for abdominal, cardiovascular, thoracic and vascular surgeries."
Easy fix as you state!
https://www.unitedhealthproductsinc.com/press-releases/2019/10/18/united-health-products-announces-positive-results-from-hemostyp-human-clinical-trial
$5-10+
Easy fix as you state!
https://www.unitedhealthproductsinc.com/press-releases/2019/10/18/united-health-products-announces-positive-results-from-hemostyp-human-clinical-trial
$5-10+
Recent UEEC News
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/22/2026 08:05:56 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2026 08:00:44 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 05/15/2026 04:15:15 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 05/11/2026 08:05:55 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 04/15/2026 09:11:17 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 01/15/2026 10:01:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/22/2025 10:20:37 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 07:44:29 PM
- Life Sciences Virtual Investor Forum: Presentations Now Available for Online Viewing • GlobeNewswire Inc. • 09/18/2025 12:35:00 PM
- United Health Products to Present at the Life Sciences Virtual Investor Forum September 18th • GlobeNewswire Inc. • 09/16/2025 08:10:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 07:41:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/16/2025 01:53:36 PM
